Dr. Kausalya Santhanam Retires As Independent Director From Sequent Scientific
Dr. Kausalya Santhanam completed her tenure and retired from the position of Independent Director of Sequent Scientific Limited on October 27, 2024.
Dr. Kausalya Santhanam is a registered patent agent with both the USPTO and India. After eight years of research in India and the United States, she joined CuraGen Corporation, a biopharmaceutical business in the United States, to work in the Intellectual Property Department. She is currently an intellectual property consultant for biotechnology and biopharmaceutical corporations in India and the United States.
